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Sex determination of mammalian germ cells occurs
during fetal development and depends on signals
from gonadal somatic cells. Previous studies have
established that retinoic acid (RA) triggers ovarian
germ cells to enter meiosis and thereby commit to
oogenesis, whereas in the developing testis, the
enzyme CYP26B1 degrades RA and germ cells are
not induced to enter meiosis. Using in vitro and
in vivo models, we demonstrate that fibroblast
growth factor 9 (FGF9) produced in the fetal testis
acts directly on germ cells to inhibit meiosis; in addi-
tion, FGF9 maintains expression of pluripotency-
related genes and upregulates markers associated
with male germ cell fate. We conclude that two
independent and mutually antagonistic pathways
involving RA and FGF9 act in concert to determine
mammalian germ cell sexual fate commitment and
support a model in which the mitosis/meiosis switch
is robustly controlled by both positive and negative
regulatory factors.
INTRODUCTION
Germ cells play a uniquely important role in biology, providing
a mechanism for sexual reproduction and for passing genetic
legacy from one generation to the next. This role calls for
a mode of cell division, meiosis, that results in formation of
haploid gametes. How germ cells switch from replicative cell
division (mitosis) to meiosis, and how germ cells in the fetus
choose between spermatogenesis and oogenesis, remain key
questions in reproductive biology.
Much of what is known about mammalian germ cells derives
from studies in the mouse. Germ cells arise in mice before
gastrulation, around 7 days post coitum (dpc), migrate for
several days as the embryo elongates and organizes its body
plan, and colonize the newly formed gonadal primordia around
10.5 dpc. Over the following days, they begin their complex
path of differentiation into oocytes or sperm. The choice of
germ cell sexual fate is dictated by cues from the somatic
cells of the gonad (Adams and McLaren, 2002; McLaren, 1981;440 Developmental Cell 19, 440–449, September 14, 2010 ª2010 ElsMcLaren and Southee, 1997; Palmer and Burgoyne, 1991).
Whether XX or XY in chromosomal constitution, germ cells
are triggered to enter meiosis in a developing ovary, thereby
committing to oogenesis. In a developing testis, germ cells do
not enter meiosis but instead go into a state of mitotic quies-
cence (G0/G1 arrest) and express markers characteristic of
commitment to the spermatogenic fate. The period from coloni-
zation of the gonad until either entry into meiosis or mitotic arrest
is critical: the sexual fate of the germ cells must be in accord
with the sex of the gonad, or infertility and/or cancer will result
(Skakkebaek et al., 1998).
Recent studies have demonstrated that the signalingmolecule
retinoic acid (RA) triggers fetal germ cells to enter meiosis (Baltus
et al., 2006; Bowles et al., 2006; Koubova et al., 2006; MacLean
et al., 2007). The meiosis-inducing role of RA has been demon-
strated also in rats (Li and Clagett-Dame, 2009) and likely also
operates in chickens and amphibians (Smith et al., 2008; Walla-
cides et al., 2009). RA is produced in the mesonephros and is
postulated to diffuse or flow into the adjacent gonad (Bowles
et al., 2006). In the developing ovary, high levels of RA induce
markers of meiosis (Bowles et al., 2006; Koubova et al., 2006),
including the premeiotic marker Stimulated by retinoic acid
(Stra8), an essential gatekeeper of meiosis and a probable direct
target of RA signaling (Baltus et al., 2006; Menke et al., 2003;
Oulad-Abdelghani et al., 1996). In the developing testis, germ
cells are not triggered to enter meiosis because RA is degraded
by a P450 enzyme, CYP26B1 (Bowles et al., 2006; Koubova
et al., 2006; MacLean et al., 2007). In Cyp26b1 null testes, XY
germ cells enter meiosis and progress to at least the pachytene
stage of meiosis I during fetal development (Bowles et al., 2006;
MacLean et al., 2007), confirming the importance of the RA/
CYP26B1 signaling system in vivo.
The existence of an ovarian meiosis-inducing factor (Byskov,
1974; Byskov and Saxen, 1976) and/or a testicular meiosis-
inhibiting factor (Francavilla and Zamboni, 1985; McLaren,
1984) had been predicted for some decades (for review, see
Bowles and Koopman, 2007). Although RA showed many of
the properties predicted for a meiosis-inducing factor, the
finding that the role of a meiosis inhibitor in the testis might
be carried out by a cytoplasmic enzyme (CYP26B1) was contrary
to the prediction that it would be a secreted factor. That
expectation was based on the observation that some XY
germ cells lodged ectopically in the XYmesonephros are spared
entry into meiosis while all ectopic XX germ cells in an XX
mesonephros do enter meiosis (McLaren, 1984). It was furtherevier Inc.
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cultured mouse testes occasionally enter meiosis when all
secretion is inhibited by use of the compound Brefeldin A (Best
et al., 2008). Together, these observations support the concept
that meiosis in the testis is actively suppressed through the
action of a secreted factor, in addition to the absence of RA.
We hypothesized that the growth factor FGF9might play a role
in this system, based on a number of published observations.
Fgf9 is initially expressed in gonads of both sexes, but its expres-
sion is greatly upregulated in the developing testis shortly after
SRY and SOX9 are activated in pre-Sertoli cells (Colvin et al.,
2001a, Nef et al., 2005). FGF9 has a known role in somatic sex
determination: deletion of Fgf9 leads to male-to-female sex
reversal (Colvin et al., 2001a; Kim et al., 2006; Schmahl et al.,
2004). In addition, it has been reported that in XY but not XX
Fgf9 null embryos, most germ cells die by 12.5 dpc, suggesting
a sex-specific role for FGF9 in germ cell survival (DiNapoli et al.,
2006). Some of the surviving XY germ cells expressed the
meiotic marker gH2AX at 14.5 dpc, as might be expected in an
ovarian environment, given the likely loss ofCyp26b1 expression
and consequent exposure to RA in XY Fgf9 null gonads.
Although the reason for the loss of germ cells in XY Fgf9 null
gonads has remained obscure, these results suggest profound
effects of FGF9 on germ cell biology and leave open the possi-
bility of an additional role for FGF9 in directly influencing germ
cell sexual fate.
In this study, we show that FGF9 plays a critical and direct role
in germ cell sex determination. We show, using ex vivo gain- and
loss-of-function studies in gonads and isolated germ cells, and
in vivo analysis of Cyp26b1-, Fgf9-, and double-knockout
embryos, that FGF9 acts directly on germ cells to antagonize
their entry into meiosis, making them less responsive to RA.
We show that FGF9 signaling plays a further role, maintaining
pluripotency of germ cells and actively promoting a male fate.
Our data suggest a model whereby germ cell sexual fate is
determined by the relative abundance of FGF9 and RA. This
system, incorporating both positive and negative regulatory
cues, imparts stability at the crucial stages of germ cell sexual
determination.
RESULTS
Germ Cells in Cyp26b1 Null Testes Differ from Germ
Cells in Wild-Type Ovaries
Initial analyses of Cyp26b1 null testes indicated that XY germ
cells exposed to aberrantly high levels of endogenous RA prog-
ress into meiosis and through the pachytene stage of meiosis I,
as assessed by expression of the premeiotic marker, Stra8, the
meiotic marker Sycp3 (Synaptonemal complex protein 3), and
by histological and cytogenetic criteria (Bowles et al., 2006;
MacLean et al., 2007). We reasoned that if a diffusible meiosis-
inhibiting substance were present in the XY gonad, then some
aspects of this progression might differ between germ cells in
Cyp26b1 null XY gonads and those in Cyp26b1 null XX gonads,
even though both are exposed to RA.
To test this hypothesis, we used quantitative real-time RT-
PCR (qRT-PCR) to compare the levels of Stra8 gene expression
in wild-type XX and XY gonads, and XX and XY Cyp26b1 null
gonads at 12.5 dpc (Figure 1A), a day earlier than previous,Developmennonquantitative analyses (Bowles et al., 2006). First, as
expected, Stra8 expression was more robust in XY Cyp26b1
null relative to XY wild-type testes. Second, Stra8 expression
levels were higher in XX Cyp26b1 null relative to XX wild-type
ovaries (Figure 1A), consistent with our previous observation
thatCyp26b1 is expressed at 11.5 dpc before subsiding in devel-
oping ovaries (Bowles et al., 2006); it remains to be determined
whether the higher levels of Stra8 in the Cyp26b1 null ovaries
result in premature entry into meiosis in these germ cells. Third,
although Stra8 was upregulated in XY Cyp26b1 null gonads
compared with wild-type XY gonads, the level of expression
was significantly lower than that seen in XXCyp26b1 null gonads
(Figure 1A). Because germ cells are exposed to RA in both XY
and XX gonads when CYP26B1 is absent, this last observation
suggests that some factor(s) in the testicular environment act
to antagonize the initial meiosis-inducing actions of RA. It has
been suggested that NANOS2 prevents Stra8 expression
(Suzuki and Saga, 2008), but we did not find Nanos2 to be upre-
gulated in the XY Cyp26b1 null testis at 12.5 dpc (Figure S1A
available online).
We next compared expression of markers of more advanced
stages of meiosis in wild-type XX and XY gonads, and XY
Cyp26b1 null gonads, at 15.5 dpc. Expression of Sycp3, Dmc1
(dosage suppressor of mck1 homolog, meiosis-specific homolo-
gous recombination [yeast]), and Spo11 (sporulation protein,
meiosis-specific, SPO11 homolog) was high in XX gonads and
low in XY gonads, reflecting the advanced progression of
meiosis in germ cells of the ovary but not the testis at that
stage (Figure 1B). However, expression of these markers in XY
Cyp26b1 null gonads was intermediate between the levels
observed in wild-type XX and XY gonads (Figure 1B), further
supporting the concept of a meiosis inhibitor that operates inde-
pendently of CYP26B1 in the testis.
We also examined a range of male germ cell fatemarkers in XY
Cyp26b1 null gonads at 15.5 dpc. No expression of male germ
cell fate markers Nanos2, Dnmt3L, or Tdrd1 was detected in
germ cells of the XY Cyp26b1 null gonads (see Figure S1B),
which is not surprising given that the germ cells in these gonads
are well advanced in meiosis at this stage (Figure 1B, and see
below).
Finally, we compared expression of the pluripotency markers
Oct4 and Sox2 in wild-type and Cyp26b1 null gonads at
15.5 dpc. These markers are expressed by germ cells from the
time of their specification, and Oct4 is normally detectable in
XY germ cells in a testicular environment until at least 17.5 dpc
(Maldonado-Saldivia et al., 2007; Western et al., 2005). In
contrast, Oct4 and Sox2 are normally downregulated as germ
cells enter meiosis in XX gonads and expression is undetectable
by 14.5–15.5 dpc (Maldonado-Saldivia et al., 2007; Pesce et al.,
1998;Western et al., 2005). Unexpectedly, we found that expres-
sion of pluripotency markers Oct4 and Sox2 was not downregu-
lated in XY Cyp26b1 null gonads relative to wild-type XY gonads
at 15.5 dpc (Figure 1C). Immunohistochemical analyses using
antibodies to the meiotic marker gH2AX (a phosphorylated
histone variant) (Hunter et al., 2001) and the meiotic structural
protein SYCP3 confirmed that germ cells in XY Cyp26b1 null
testes, like those in XX gonads, were in an advanced stage of
meiosis, and yet retained expression of OCT4 in their germ cells
(Figures 1D, S1C, and S1D).tal Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc. 441
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Figure 1. XY Germ Cells in the Cyp26b1 Null Embryo
Are Distinct from Both XY Germ Cells and XX Germ
Cells
(A) qRT-PCR analysis of expression of Stra8 in 12.5 dpc
urogenital ridge (UGR) from genotypes of Cyp26b1-knockout
litters as indicated. Bars indicate the mean + 1 SEM, n = 5,
11, 5, 7, 6, and 5 individual embryos, respectively. Mvh (also
known as Ddx4) was used as the normalization control.
(B) qRT-PCR analysis of Sycp3, Dmc1, and Spo11 expression
at 15.5 dpc in XY wild-type (Wt), XYCyp26b1 null (KO), and XX
Wt gonads. Bars indicate the mean + 1 SEM, n = 4 individual
embryos. Mvh was used as the normalization control.
(C) qRT-PCRanalysis ofOct4 andSox2 expression at 15.5 dpc
in three genotypes as in (B). Bars indicate the mean + 1 SEM,
n = 4 individual embryos. Mvh was used as the normalization
control.
(D) Confocal images of gonad tissue at 15.5 dpc in three geno-
types as in (B). MVHmarks germ cell cytoplasm, gH2AXmarks
germ cells in meiosis, SYCP3 shows meiotic chromosome
architecture, and OCT4 marks pluripotent germ cells.
Scale bar, 10 mm. See also Figure S1.
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FGF9 Regulates Sex-Specific Germ Cell FateTogether, these findings indicate that, although genetic abla-
tion of Cyp26b1 in XY gonads results in levels of RA sufficient
to induce the premeiotic marker Stra8 and to trigger progression
throughmeiosis, germ cells in these gonads do not show aprofile
of marker expression typical of germ cells in an ovarian environ-
ment. These observations point to the existence of additional
factor(s) produced in the developing testes that have at least
two activities, one involved in impeding the female pathway of
germ cell differentiation (i.e., initiation of meiosis), and another
in promoting male germ cell behavior (i.e., retention of markers
such as OCT4).
FGF9 Acts to Inhibit Meiosis by Making Germ Cells Less
Responsive to RA in Mouse Cultured Gonads
We hypothesized that FGF9 might have a role in influencing
germ cell fate in the testis. Fgf9 is initially expressed in gonads
of both sexes (Kim et al., 2006), but by 11.5 dpc it is much
more highly expressed in the developing testis than the ovary
(Figure 2; Nef et al., 2005). A recent study has pointed to a role442 Developmental Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc.for FGF9 in inhibiting meiotic entry in cultured
mouse gonads (Barrios et al., 2010). Indeed, when
we added FGF9 to cultured XX urogenital ridges
(UGRs) at 11.5 dpc, Stra8 expression was signifi-
cantly lower after 24 hr than in control XX samples
(Figure 2C).
One possible explanation for this effect is that
FGF9 drives Cyp26b1 expression in somatic cells
of the developing testis: like Fgf9, Cyp26b1 is
expressed initially in gonads of both sexes and
then upregulated in the testis (Bowles et al.,
2006). However, addition of FGF9 to mouse
UGR organ cultures did not upregulate Cyp26b1
expression over a 24 hr period (Figure 2D). Like-
wise, manipulation of RA levels in cultured gonads,
or in vivo by genetic ablation of Cyp26b1, had
no effect on FGF9 expression (Figures S2A and
S2B). Hence, Stra8 expression is antagonized inFGF9-treated XX UGRs independently of the RA/CYP26B1
pathway.
We also carried out a series of experiments involving chemical
agonists and antagonists in XY and XX UGR explant cultures, to
examine further the relationship between FGF9 and RA in this
system. Inhibition of CYP26B1 using the P450 inhibitor ketoco-
nazole, which would be expected to augment endogenous RA
activity, led to greatly enhanced Stra8 expression, consistent
with previous findings (Bowles et al., 2006; Koubova et al.,
2006) (Figures 2E and 2F, columns 5 and 1). In XY UGR explants,
simultaneous inhibition of CYP26B1 and FGF receptors caused
even greater upregulation of Stra8, indicating that RA is more
capable of inducing Stra8 expression in the absence of FGF
signaling (Figure 2E, columns 6 and 5). In XX UGR explant
culture, no such additive effect was observed, presumably
because there is little endogenous FGF9 present in such cultures
(Figure 2F, columns 6 and 5). Importantly, treatment of XY or XX
cultures with FGFR antagonist alone did not augment Stra8
expression, indicating that FGF9 does not work by inhibiting
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Figure 2. FGF9 Is Male-Specifically Expressed at 11.5
dpc and Affects Expression of Stra8 in Gonadal
Culture without Affecting Cyp26b1 Expression
(A) Whole-mount in situ hybridization for Fgf9 at 11.5 dpc in XY
and XX UGR. m, mesonephros; g, gonad.
(B–D) (B) qRT-PCR analysis of Fgf9 expression at various time
points in XY and XX gonad samples. Bars represent mean + 1
SEM, n = 3 individual embryos. 18S rRNA was used as the
normalization control. UGRs (11.5 dpc) were cultured in the
presence of 50 ng/ml of FGF9 for 24 hr and Stra8 (C) and
Cyp26b1 (D) expression was analyzed by qRT-PCR. Bars
represent mean + 1 SEM, n = 3 independent experiments.
18S RNA was used as the normalization control.
(E and F) 11.5 dpc XY (E) or XX (F) UGRswere cultured for 18 hr
with FGFR antagonist (FGFRant, SU5402, 5 mM), RAR antag-
onist (RARant, AGN193109, 5 mM), FGF9 (50 ng/ml), or keto-
conazole (Cyp.ant, 10 mM) as indicated. qRT-PCR analysis
of Stra8 expression is shown (using Mvh as the normalization
control).
Bars represent mean and 1 SEM, n = 4 or more independent
experiments. See also Figure S2.
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FGF9 Regulates Sex-Specific Germ Cell Fatethe expression of Stra8 per se, but by making germ cells less
responsive to RA (Figures 2E and 2F, columns 2 and 1).
We tested also whether the augmented Stra8 expression
observed in ketoconazole-treated cultures could be overcome
by addition of exogenous FGF9. In XY cultures, additional
FGF9 did not diminish Stra8 expression in the presence of
ketoconazole, although there was some diminution in XX
cultures (Figures 2E and 2F, columns 5 and 7). Presumably the
different responses in the two sexes reflect the fact that XY
cultures already contain endogenous FGF9 and, hence, may
show no additional response when exogenous FGF9 is added.
To address the issue of specificity of the CYP26B1 inhibitor
ketoconazole, we tested the effect of treating in the presence
of RAR antagonist (Figures 2E and 2F, columns 8 and 5). The
effect of ketoconazole on Stra8 expression was greatly dimin-
ished in the presence of RAR antagonist, suggesting that, as
intended, the effect of ketoconazole in these cultures is to inhibit
the degradation of RA. Overall, these data indicate that RA and
FGF9 act in the gonad to oppositely influence expression of
the meiotic gatekeeper gene, Stra8. Moreover, these results
suggest that RA is instructive in the induction of meiosis and
that the absence of FGF9 is permissive.
FGF9 Acts Directly on Germ Cells
Although FGF9 antagonized Stra8 expression in organ culture
(Figure 2C; Barrios et al., 2010), it remained possible that theDevelopmental Cell 19, 44effects might be mediated by somatic sex reversal,
given the known role of FGF9 in maintaining Sox9
expression (Kim et al., 2006). That is, administration
of FGF9 to cultured XX gonads might upregulate
Sox9 expression, which might then cause Sertoli
cell differentiation and result in a signaling cascade
that inhibits germ cell meiosis. On the other hand,
blockade of FGF signaling in cultured XY gonads
might result in loss ofSox9 expression and transdif-
ferentiation of Sertoli cells, leading to a promeiotic
signaling cascade. To assess the effects of FGF9on germ cells in isolation, we purified them by immunomagnetic
sorting (Pesce and De Felici, 1995) and established a serum-
free germ cell culture system in order to exclude confounding
effects of serum-borne RA and growth factors. Using this
method, we were able to demonstrate that RA itself acts directly
and dose-dependently on germ cells to induce Stra8 expression
(Figure S3).
We next tested the effect of FGF9 in isolated germ cell culture.
We isolated separate XY and XX populations of germ cells from
11.5 dpc gonads and tested them in 18 hr serum-free culture.
When germ cells of either population were treated with FGF9
(25 ng/ml), baseline levels of Stra8 expression decreased after
18 hr, whereas treatment with RA (0.01 mM) strongly induced
Stra8 expression (Figure 3A). The level of Stra8 expression was
attenuated when FGF9 and RA were applied together. These
experiments show that the effects of FGF9 in this system occur
through direct action on germ cells, and are not indirect effects of
changes to somatic cells of the gonad. Moreover, these studies
demonstrate that 11.5 dpc germ cells respond to FGF9 and RA
in the same manner, regardless of whether they are XX or XY
or whether they have been exposed to a testicular or ovarian
environment.
A corollary of this finding is that gonadal germ cells must
express suitable FGF receptors (FGFRs). Previous studies
have examined FGFR isoforms expressed by migratory germ
cells that were purified by fluorescence-activated cell sorting0–449, September 14, 2010 ª2010 Elsevier Inc. 443
E
xp
n.
 re
l. 
to
 M
vh
A B
***
Stra8
***
FG
F9
FG
F9
 &
 R
A RA
_
FG
F9
FG
F9
 &
 R
A RA
_
Actin
Oct4
KitL
Fgfr1IIIc
Fgfr1IIIb
Fgfr3IIIb
Fgfr2IIIb
Fgfr3IIIc
Fgfr4
Fgfr2IIIc
Amh
Fgf9
Sox9
1
1
.5
 G
C
s
1
1
.5
 S
o
m
a
1
1
.5
 E
m
b
ry
o
-R
T
E
-C
A
D
./F
G
FR
2
C
XY gonad 12.5 dpc
Figure 3. FGF9 Acts Directly on Germ Cells to Atten-
uate Stra8 Expression
(A) Germ cells were isolated from XY and XX pools of sexed
gonads at 11.5 dpc and each population was cultured for
18 hr with FGF9 (25 ng/ml), RA (0.01 mM), or both. qRT-PCR
analysis of Stra8 expression is shown. Bars represent mean
and 1 SEM, n = 4 independent experiments. Mvh was used
as the normalization control. The graph shows results from
XY samples (left) and XX samples (right).
(B) 11.5 dpc gonads were dissociated and germ cell and
somatic cell populations were purified by FACS sorting.
Whole-embryo sample 11.5 dpc is included as a control.
Fgfr1IIIc, Fgfr2IIIb, and Fgfr2IIIc isoforms are expressed by
germ cells (arrows).
(C) FGFR2 (green) is observed concentrated at or near the cell
surface (red, E-cadherin-positive) of germ cells in a 12.5 dpc
testis.
Scale bar, 10 mm. See also Figure S3.
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FGF9 Regulates Sex-Specific Germ Cell Fate(FACS) at 10.5 dpc, just before colonization of the genital ridges
(Takeuchi et al., 2005). The predominant FGFR isoform tran-
scripts expressed by germ cells at that time point were Fgfr1-IIIc
and Fgfr2-IIIb. We analyzed Fgfr gene expression in FACS-
sorted germ cells using 11.5 dpc gonads as the starting material
(Figure 3B). Like 10.5 dpc germ cells, 11.5 dpc germ cells
expressed Fgfr1-IIIc; FGFR1-IIIc is a possible but weak receptor
for FGF9 (Ornitz et al., 1996; Takeuchi et al., 2005). However,
10.5 dpc and 11.5 dpc germ cells differed in Fgfr2 isoform
expression. Fgfr2-IIIb was the only form expressed by 10.5 dpc
germ cells (Takeuchi et al., 2005), whereas 11.5 dpc germ cells
also expressed Fgfr2-IIIc (Figure 4). Fgfr2-IIIb and -IIIc are alter-
natively spliced transcripts of the gene Fgfr2; they encode
FGFR2 proteins that differ in the third loop of the Ig-like extracel-
lular ligand-binding domain. Unlike FGFR2-IIIb, FGFR2-IIIc is
a high affinity receptor for FGF9 (Eswarakumar et al., 2005;
Ornitz et al., 1996). Our data suggest that germ cells undergo
FGFR2 isotype switching whichmakes them particularly compe-
tent to respond to FGF9 after they enter the gonad.
We next examined the subcellular localization of FGFR2 in
germ cells. At 12.5 dpc, the cell adhesion molecule E-cadherin
is highly expressed on the surface of XY germ cells in a testicular
environment. Antibodies recognizing FGFR2 were detected with
a peripheral pattern of punctate staining, at and near the germ
cell surface, showing some overlap with E-cadherin and some
staining subjacent to the surface membrane (Figure 3C).
FGF9 Impedes the Upregulation of Stra8 by RA In Vivo
Our in vitro observations involving cultured genital ridges and
purified germ cells suggested that FGF9 acts directly on germ
cells to antagonize entry into meiosis. To investigate the role of
FGF9 in this system in vivo, we next set out to analyze the effects
of genetic ablation of Fgf9 in mice.
Because Stra8 expression was reduced in XY Cyp26b1 null
gonads relative to XX Cyp26b1 null counterparts at 12.5 dpc444 Developmental Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc.despite the presence of RA in both (Figure 1A), we
first wanted to test the hypothesis that additional
ablation of FGF9 activity in these gonads might
rescue Stra8 expression to wild-type levels. How-
ever, XY Fgf9 null mice show male-to-female sexreversal (Colvin et al., 2001a; Kim et al., 2006; Schmahl et al.,
2004), and therefore germ cells are exposed to ovary-specific
signals, precluding analysis of the direct role of FGF9 on germ
cell development. We reasoned that loss of one copy of Fgf9
from Cyp26b1 null gonads might partially rescue the reduced
Stra8 levels observed in those gonads, without affecting somatic
development of the gonads.
We first confirmed that Fgf9 expression is reduced in Fgf9+/
testes, relative to wild-type testes, at 12.5 dpc (Figure 4A). We
then crossed Cyp26b1+/ and Fgf9+/ animals to produce
embryos of a range of genotypes and analyzed Stra8 expression
in the gonads at 12.5 dpc. XY Cyp26b1/;Fgf9+/ germ cells
expressed significantly more Stra8 at 12.5 dpc than did XY
Cyp26b1/;Fgf9+/+ germ cells (Figure 4B). In the same samples,
Sox9 expression was not decreased in the XY Cyp26b1/;
Fgf9+/ gonads, indicating that the absence of one copy of
Fgf9 had not adversely affected testicular somatic development
(Figure 4C). This result confirms that, in vivo, FGF9 acts to
prevent germ cells from upregulating Stra8 and that this effect
is independent of any sex-reversal of the gonadal soma.
In the course of these experiments, we re-examined the germ
cell phenotype of Fgf9 null mice. Surprisingly, we found that in
homozygous XY Fgf9-knockout sex-reversed ovaries, germ
cell numbers were similar to those in wild-type XX ovaries
at 12.5 dpc, as assessed by alkaline phosphatase staining
(Figure S4A). These findings differ from a previous analysis of
Fgf9 null mice demonstrating that 97% of germ cells in the XY
null gonad undergo apoptosis between 11.5 and 12.5 dpc
(DiNapoli et al., 2006). The reason for the different phenotype
is not clear, but may be related to differences in substrain or
breeding regime between the two studies. As expected given
the location of these germ cells in an ovarian somatic environ-
ment, germ cells in XY Fgf9 null ovaries were similar to XX
germ cells of wild-type ovaries at 15.5 dpc for a range of markers
of meiosis (Stra8, Sycp3, Dmc1, and Spo11 mRNA; gH2AX and
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Figure 4. FGF9 Acts In Vivo to Attenuate Stra8 Expression in the XY
Gonad
UGRs were recovered at 12.5 dpc from various genotypes of Cyp26b1-
knockout and Cyp26b1-knockout /Fgf9-knockout crosses and qRT-PCR
was carried out for Stra8 expression (using Mvh as the normalization control)
and Fgf9 and Sox9 expression (using Tbp as the normalization control).
(A) In the Fgf9 heterozygous XY gonads (XY het), Fgf9 expression is signifi-
cantly reduced compared with levels in the XY wild-type gonad (XY Wt).
(B) In the Cyp26b1 null XY samples, Stra8 expression is significantly higher
when one copy of Fgf9 is deleted (XY Cyp26b1 KO;Fgf9 het), than when
both copies of Fgf9 are intact (XY Cyp26b1 KO; Fgf9 Wt).
(C) There is no significant difference in Sox9 expression when XY Cyp26b1
KO;Fgf9 het and XY Cyp26b1 KO; Fgf9Wt samples are compared, indicating
that Fgf9 haploinsufficiency does not adversely affect male gonadal develop-
ment at 12.5 dpc.
Bars represent mean + 1 SEM, n = 5, 8, 5, 7, 4, 4, 7, 5, 4, 5, 4, and 3 individual
embryos, respectively.
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FGF9 Regulates Sex-Specific Germ Cell FateSYCP3 protein), pluripotency (Oct4, Sox2mRNA; OCT4 protein),
and male fate (Nanos2, Dnmt3l) (Figures S4B and S4C).
FGF9 Actively Promotes Male Germ Cell Fate
Our analysis of Cyp26b1 null testes revealed that although XY
germ cells express meiotic marker genes and indeed progress
through meiosis, expression of pluripotency-associated genesDevelopmenis not downregulated (Figures 1C and 1D). Because retention
of these markers is normally associated with the early male
pathway of germ cell development, these findings raise the
possibility that an additional role of FGF9 might be to actively
promote male germ cell differentiation.
We tested whether FGF9 could induce expression of male
cell fate marker genes when added to XX UGRs explanted at
11.5 dpc and cultured for 48 hr. FGF9 induced Nanos2 and
Dnmt3L expression in both XY and XX samples (Figure 5A).
Conversely, when FGFRs were blocked in the XY gonad using
a chemical antagonist (SU5402), Nanos2 and Dnmt3L were
downregulated (Figure 5B). These results are consistent with
the hypothesis that FGF9 not only inhibits the initiation of germ
cell meiosis but also that it actively pushes germ cells toward
a spermatogenic fate.
To confirm that these effects result from direct action on germ
cells and are not mediated by effects on somatic cells, we
isolated XY germ cell populations at 12.5 dpc and cultured
them in control media or in media containing FGF9 (25 ng/ml)
or RA (0.01 mM) (Figure 5C). After 48 hr of culture, expression
of Oct4 and Sox2 was upregulated in XY germ cells treated
with FGF9. In addition, male fate markers Nanos2, Dnmt3L,
and P15 were upregulated consistently in the presence of
FGF9. In contrast, treatment of 12.5 dpc XY germ cells with RA
greatly induced Stra8, Sycp3, and Dmc1 and was associated
with below-baseline expression levels for pluripotency (Oct4,
Sox2) and male fate markers (Dnmt3L, Nanos2, P15). These
results suggest that germ cell sexual fate is determined by the
antagonist actions of two signaling factors, RA and FGF9, with
RA pushing germ cells toward oogenesis and FGF9 pushing
germ cells toward a male fate (Figure 6).
DISCUSSION
Here, we present evidence that mouse germ cell sexual fate is
determined by two different signaling factors, FGF9 and RA.
This work significantly extends earlier findings concerning the
dominant role of RA in the induction of meiosis and the function
of CYP26B1 as a male-specific meiosis-inhibiting factor. We
show that FGF9 makes germ cells less responsive to RA,
possibly because it forces germ cells to maintain expression of
pluripotency genes and to upregulate male germ cell fate genes,
and that both RA and FGF9 act directly on germ cells rather than
by signaling through somatic cells. These results demonstrate
that FGF9 acts as a diffusible meiosis-inhibiting substance.
The model suggested by our data is presented in Figure 6. In
the ovary, where RA levels are high and FGF9 levels low, germ
cells upregulate Stra8, downregulate pluripotency markers,
and enter meiosis. In the developing testis, where RA is
degraded by CYP26B1 and FGF9 levels are high, germ cells
do not upregulate Stra8 and instead maintain expression of
pluripotency markers and upregulate male germ cell fate marker
genes Nanos2, Dnmt3L, and P15. Although some elements of
this model have been proposed recently (Barrios et al., 2010),
we greatly extend the evidence offered in that study. In partic-
ular, we base our conclusions on in vivo as well as in vitro studies
and, importantly, we demonstrate a direct effect of FGF9 on
germ cell sexual fate determination without the confounding
effect of somatic cell influences.tal Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc. 445
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Figure 5. FGF9 Drives the Expression of Male
Germ Cell Fate Markers in Gonad and Germ Cell
Culture
UGRs (11.5 dpc) were cultured for 48 hr in the presence
or absence of FGF9 (50 ng/ml, A) or FGFR antagonist
(SU5402, 5 mM, B) and qRT-PCR was used to test
expression of Nanos2 and Dnmt3l (using Mvh as the
normalization control). Bars represent mean + 1 SEM,
n = 3 independent experiments. (C) XY germ cells were
isolated from testes at 12.5 dpc and cultured for 48 hr in
the presence of FGF9 (25 ng/ml) or RA (0.01 mM). qRT-
PCR was used to test expression of meiosis markers
(Stra8, Sycp3, Dmc1), pluripotency markers (Oct4, Sox2)
and male germ cell fate markers (Nanos2, Dnmt3l, and
P15). Bars represent mean + 1 SEM, n = 5 independent
experiments. For each gene, expression is plotted relative
to maximal expression for that gene (using Mvh as the
normalization control). Statistical significance was calcu-
lated based on raw expression values from each indepen-
dent experiment.
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FGF9 Regulates Sex-Specific Germ Cell FateAntagonism between FGFs and RA is a recurring theme in
development, in each instance associated with cell lineage
decisions (for review, see Diez del Corral and Storey, 2004;
Niederreither and Dolle, 2008). For example, in the elongating
embryo axis, FGF8 acts to maintain ‘‘stemness’’ in the caudal
region while RA stimulates differentiation in the ventral domain
(Diez del Corral et al., 2003). FGF and RA also act antagonisti-
cally during limb bud development (Mercader et al., 2000). Our
study provides another example of this phenomenon: RA
triggers germ cells to enter meiosis, thereby committing to
a female fate, while FGF9 acts to maintain pluripotency in germ
cells and to push them toward a male fate.
The finding that FGF9 plays a key role in regulating germ cell
sexual fate helps clarify a number of previous observations
relating to the behavior of germ cells resulting from a variety of
genetic and pharmacological perturbations. In Cyp26b1 null446 Developmental Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc.mice, XY germ cells in a testis are exposed to
RA and so expressStra8 and enter and progress
through meiosis (Bowles et al., 2006; MacLean
et al., 2007). Before birth, however, all of thesegerm cells have been removed by apoptosis, suggesting that
there is something abnormal about their development (MacLean
et al., 2007). In this study, we find that XY germ cells in Cyp26b1
null gonads do not downregulate Oct4 and Sox2, as is normal
for germ cells entering meiosis (Pesce et al., 1998). Our data
suggest that FGF9 acts to maintain germ cell pluripotency genes
in Cyp26b null gonads despite the fact that germ cells are in
meiosis, a situation very much at odds with normal germ cell
development. It may be that germ cells at the cross-roads of
these mixed signals are frequently removed by apoptosis. The
postulated ‘‘antagonism’’ between the testis and meiotic germ
cells suggested by other studies (McLaren, 1984; Wai-sum and
Baker, 1976; Vigier et al., 1987; Yaoet al., 2003)may reflect a situ-
ation similar to that observed in theCyp26b1 null testis, with both
meiotic and pluripotency markers being expressed simulta-
neously in germ cells and leading to their removal by apoptosis.Figure 6. RA and FGF9 Act Antagonistically
to Determine Germ Cell Fate
Germ cell sexual fate is determined by two
signaling molecules produced by the somatic cells
of the gonad, FGF9 and RA.Cyp26b1 and Fgf9 are
highly expressed in the testis (blue) but are down-
regulated in the ovary (pink). Since CYP26B1
degrades endogenous RA, RA levels are low in
the testis while FGF9 levels are high. In the ovary,
RA is not degraded and FGF9 levels are low. RA
and FGF9 both act directly on germ cells (one
white cell shown) to upregulate Stra8 (RA) or to
prevent its upregulation (FGF9). Stra8 expression
in gonadal germ cells is essential for entry into
meiosis, by an unknown mechanism. FGF9 acts
directly on germ cells to antagonize Stra8 expres-
sion, maintain expression of pluripotencymarkers,
Oct4 and Sox2, and to induce male germ cell fate
markers, Nanos2, Dnmt3L, and P15.
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FGF9 Regulates Sex-Specific Germ Cell FateOur findings also help to explain observations made inNanos2
null mice (Suzuki and Saga, 2008). When Nanos2 is deleted, XY
germ cells die by apoptosis. However, if apoptotic death is
rescued by deletion of theBax1 gene (which encodes a proapop-
totic protein), some XY germ cells do not commit to the male
program of development but instead enter meiosis, albeit about
2 days later than their XX counterparts. Presumably expression
of both Fgf9 and Cyp26b1 is normal in Nanos2 null XY gonads,
so the XY germ cells do not enter meiosis on schedule, i.e.,
with Stra8 expression beginning at 12.5 dpc as is the case for
XX germ cells in a wild-type background. It seems likely that, in
the absence of Nanos2, male fate is not ‘‘locked in’’ and, there-
fore, XY germ cells remain vulnerable to the influence of RA as
late as 14.5–15.5 dpc, after CYP26B1 levels start to fall (Suzuki
and Saga, 2008). In the wild-type situation, Nanos2 expression
appears to be regulated by both FGF9 (this study; Barrios
et al., 2010) and RA (this study; Barrios et al., 2010; Suzuki and
Saga, 2008). It is possible that apparent repression of Nanos2
expression by RA (Barrios et al., 2010; Suzuki and Saga, 2008)
reflects mutually exclusive expression of Stra8 and Nanos2 in
germ cells.
Our findings likely also explain the observation that treatment
of XY gonads in culture at 11.5 dpc with Brefeldin A, a potent
inhibitor of secretion, causes some germ cells at one end of
the gonads to embark on meiosis (Best et al., 2008). If FGF9
secretion by pre-Sertoli cells were blocked at 11.5 dpc, XY
germ cells might be sensitive to RA even at concentrations that
are not normally sufficient to induce Stra8 expression in the
testis. We would predict that any meiotic germ cells would be
located at the anterior end of the gonad where RA is likely to
be present at highest levels at 11.5 dpc (Bowles et al., 2006).
Interestingly, during normal development, a small cohort of
meiotic germ cells is observed transiently at the anterior end of
the XY gonad near themesonephros/gonad junction at 14.5 dpc:
these cells are rapidly removed by apoptosis (McLaren, 1984;
Yao et al., 2003).
In XXWnt4 null gonads, germ cells begin to enter meiosis but
then degenerate (Yao et al., 2004). WNT4 and FGF9 are believed
to act antagonistically to orchestrate somatic sex determination
and, in support of this, FGF9 protein is readily detectable in XX
Wnt4/ gonads, but not in XX Wnt4+/ littermates at 12.5 dpc
(Kim et al., 2006). Hence, in a XX Wnt4 null environment, we
would predict high RA levels but also high levels of FGF9. As in
XYCyp26b1 null gonads, the high RA levels likely are responsible
for initiating meiosis. Based on our findings, we would predict
that continued exposure to FGF9 would cause the germ cells
to retain expression of pluripotency markers, a factor that may
lead to their removal by apoptosis. Thus, it is likely that the
germ cell phenotype observed in Wnt4 null embryos reflects an
abnormal FGF9/RA balance in the gonad.
A model whereby both RA and FGF9 are involved in germ cell
fate determination is compatible with previous ideas concerning
the timing of meiotic susceptibility and of commitment to
oogenic or spermatogenic fates. It has been suggested that
the ‘‘window of opportunity’’ for XY germ cells to be triggered
to enter meiosis closes by about 12.5 dpc and that some XY
germ cells are already committed by 11.5 dpc (Adams and
McLaren, 2002). In contrast, XX germ cells are reportedly not
committed until 12.5–13.5 dpc (Adams and McLaren, 2002).DevelopmenThis suggests that XY germ cells are positively instructed by
a male-specific factor to commit to spermatogenesis rather
than committing to spermatogenesis because they have not
encountered RA and therefore have not entered meiosis. Our
results demonstrate that FGF9 expression is male specific by
11.5 dpc, early enough to actively commit germ cells to the
spermatogenic fate, thereby closing the window of opportunity
to adopt a meiotic fate. Although Nanos2 is clearly involved in
commitment to the spermatogenic lineage (Suzuki and Saga,
2008), it does not appear to be expressed in XY germ cells until
about 13.5 dpc (Tsuda et al., 2003). XY germ cells at 11.5 and
12.5 dpc may be refractory to meiosis because FGF9 maintains
expression of genes such as Oct4 and Sox2. However, since we
have shown that germ cells can entermeiosis without downregu-
lating pluripotency genes, perhaps the most likely explanation
is that FGF9 induces as yet unidentified intrinsic factors in XY
germ cells and that these prevent meiotic susceptibility until
NANOS2 takes over.
We provide in vitro and in vivo evidence that FGF9 acts directly
on germ cells to effect maintenance of pluripotency marker
expression. Such retained expression is a hallmark of early
male germ cell development. We show, further, that FGF9
pushes germ cells toward amale fate, asmarked by upregulated
expression of a gene that appears to be key for male fate,
Nanos2 (encoding an RNA-binding protein), as well as later
markers, Dnmt3L (encoding a de novo methylase enzyme) and
P15 (Cdkn2b, encoding an inhibitor of CDK4) in isolated germ
cell culture. Although it was recently demonstrated that exoge-
nously added FGF9 is able to induce expression of Nanos2 in
whole and dissociated organ culture (Barrios et al., 2010), we
add substantially to that work by showing that the effect of
FGF9 on germ cells is independent of any influence on somatic
cells. Because each of these marker genes is more highly
expressed in FGF9-treated than in control culture, it appears
that FGF9 actually pushes germ cells toward a male fate, rather
than merely permitting their survival in the absence of RA.
Because of the complication of the role of FGF9 in somatic
development of the gonad, ultimate proof that FGF9 instructs
male germ cell fate in vivo will require an efficient and specific
deletion of FGFR2 in fetal germ cells.
If FGF9 and RA each act as key active determinants of germ
cell sexual fate, as we propose, then a significant mystery
remains. In XY Cyp26b1 null gonads, germ cells robustly
expressed Stra8 and entered meiosis by 13.5 dpc, despite the
fact that FGF9 was presumably present at normal levels (Bowles
et al., 2006; MacLean et al., 2007). This result appears to indi-
cate, therefore, that RA is the dominant force with respect to
germ cell fate determination and that FGF9must play only a sup-
porting role. We do not believe that such an interpretation is
correct. Instead, we postulate that, in the Cyp26b1 null model,
RA has an advantage over FGF9 because RA is present earlier
than is normal, even compared with the wild-type XX gonad.
Therefore, XY germ cells in the Cyp26b1 null robustly enter
meiosis by 13.5 dpc, even in the presence of FGF9. Evidence
that this hypothesis is correct comes from our earlier observation
that germ cells in XXCyp26b1 null gonads begin to expressStra8
earlier than those in wild-type XX gonads (Bowles et al., 2006).
In summary, the present study adds a new layer of under-
standing to the problem of germ cell sex determination bytal Cell 19, 440–449, September 14, 2010 ª2010 Elsevier Inc. 447
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FGF9 Regulates Sex-Specific Germ Cell Faterevealing that FGF9 plays an important role in vivo. We propose
that while RA acts to push germ cells toward an oogenic fate,
FGF9 acts to oppose their entry into meiosis and to push them
toward a spermatogenic fate. Since RA is more abundant in
the developing ovary and FGF9 is more abundant in the devel-
oping testis, the model we propose allows for reinforcement,
and improves robustness, of the crucial decision of whether
a germ cell commits to the oogenic or spermatogenic fate.
EXPERIMENTAL PROCEDURES
Mice
Cyp26b1-knockout mice (Yashiro et al., 2004) and Fgf9-knockout mice (Colvin
et al., 2001b) were on the pure C57BL/6 background. X-linked green fluores-
cent protein (GFP) mice (Hadjantonakis et al., 1998) were on a random bred
out-bred Swiss albino background (Quackenbush strain). Oct4DPE:eGFP
studs (OG2 line) were on a CD1 background (Szabo et al., 2002). Details of
embryo collection and dissection are given in the Supplemental Experimental
Procedures.
Immunomagnetic Germ Cell Isolation
Tissues were dissociated using Cell Dissociation Buffer (GIBCO) and germ
cells were isolated using magnetic sorting (MACS, Miltenyi Biotech) as
described (Pesce and De Felici, 1995). For details see Supplemental Experi-
mental Procedures.
FACS Germ Cell Purification and Analysis of FGFR Isoform
Expression
Oct4DPE:eGFP studs were mated with wild-type CD1 females and unsexed
UGR tissue collected at 11.5 dpc. Germ cell and somatic cell populations
were separated by fluorescence-activated cell sorting (FACS) using standard
procedures. Details for FACS, preparation of RNA and cDNA, primer
sequences and conditions for PCR reactions are given in the Supplemental
Experimental Procedures.
UGR and Germ Cell Culture
Composition of media used for culture of UGRs and germ cells, culture condi-
tions, and details of culture additives are given in the Supplemental Experi-
mental Procedures.
Quantitative RT-PCR
Relative cDNA levels were analyzed by the comparative cycle time (Ct) method
of quantitative RT-PCR (qRT-PCR) with reactions including Taqman PCR
master mix (Applied Biosystems, ABI) and Taqman gene expression sets or
SYBR master mix (ABI) and standard PCR primers (Sigma Aldrich). Analysis
details and primer sets used for qRT-PCR are documented in the Supple-
mental Experimental Procedures.
Statistical Analysis
Asterisks highlight the pertinent comparisons and indicate level of statistical
significance (*p < 0.05; **p < 0.01; ***p < 0.001; ns = not significant). For details
of analyses, see Supplemental Experimental Procedures.
Immunohistochemistry
Analyses were carried out on fixed, paraffin-embedded 5 mm sections using
standard methods. For details see Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.devcel.2010.08.010.
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